|Day Low/High||3.18 / 3.26|
|52 Wk Low/High||2.65 / 5.87|
Supports Folate Receptor (FR) as a Valid Target in Non-Small Cell Lung Cancer (NSCLC)
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NBN, PZE Downgrades: CKX, DTLK, ECYT, FRPH, RCKY, SYX, TLYS, WRES Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
These under-$10 biotech stocks are within range of triggering breakout trades.